MEDICAL REFERENCES
MEDICAL REFERENCES
Cancer Cachexia and Targeting Chronic Inflammation: A Unified Approach to Cancer Treatment and Palliative/Supportive Care, MacDonald, J. Support. Oncol. 2007; 5 (4): 157-162.
Inflammation and Cancer, Coussens & Werb, Nature 2002; 420 (6917): 860-867.
Significance and Relationship Between Infiltrating Inflammatory Cell and Tumor Angiogenesis in Hepatocellular Carcinoma Tissues, Peng, Deng, Yang, et al., World J Gastroenterol. 2005; 11 (41): 6521-6524.
Inflammatory Cell Infiltration of Tumors: Jekyll or Hyde, Talmadge, Donkor, & Scholar, Cancer Metastasis Rev. 2007; 26 (3-4): 373- 400.
Bioavailability of Curcumin: Problems and Promises,Anaand, Kunnumakkara, Newman, et al., Molec. Pharm. 2007; 4 (6): 807-818.
Phase II Trial of Curcumin in Patients with Advanced
Pancreatic Cancer, Dhillon, Aggarwal, Newman, et al., Clin.Cancer Res. 2008; 14 (14): 4491-4499.
Inflammation and Prostate Cancer, Vasto, Carruba, Candore, et al., Future Oncol. 2008; 4 (5): 637-645.
Prevention and Treatment of Pancreatic Cancer by Curcumin
in Combination with Omega-3 Fatty Acids, Swamy, Citineni, et al, Nutr. Cancer 2008; 60 Suppl. 1: 81-89.
Curcumin Inhibits
Human Colon Cancer Cell Growth by Suppressing Gene Expression of Epidermal Growth Factor Receptor Through Reducing the Activity of
the Transcription Factor Egr-1, Chen, Xu & Johnson, Oncogene 2006; 25 (2): 278-287.
Phase II Trial of Curcumin in Patients
with Advanced Pancreatic Cancer, Dhillon, Aggarwal, Newman, et al., Clin. Cancer Res. 2008; 14 (14): 4491-4499.
Inhibitory Effect of Curcumin, a Food Spice from Turmeric, on Platelet-activating Factor and Arachidonic Acid-mediated Platelet Aggregation Through Inhibition of Thromboxane Formation and Ca2+ Signalling, Shah, Nawaz, Pertani, et al., Biochem. Pharmacol. 1999; 58 (7): 1167-1172.
Combination
Treatment with Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis, Cruz-Correa, Shoskes, Sanchez, et al., Clin.
Gastroenterol. Hepatol. 2006; 4 (8): 1035-1038.
Curcumin Inhibits Proliferation, Invasion, Angiogenesis and Metastasis of Different
Cancers Through Interaction with Multiple Cell Signaling Proteins, Kunnumakkara, Anand &Aggarwal, Cancer Lett. 2008;[Epub ahead
of print].
Curcumin (Diferuloylmethane) Down-regulates Expression of Cell Proliferation and Anti-apoptotic and Metastatic Gene
Products Through Suppression of I-kappaB-alpha Kinase and Akt Activation, Aggarwal, Ichikawa, Takada, et al., Mol. Pharmacol. 2006;
69 (1): 195-206.
Curcumin Down-regulates the Multidrug-resistance Mdr1b Gene by Inhibiting the PI3K/Akt/NF kappa B Pathway, Choi,
Kim, Lim, et al., Cancer Lett. 2008; 259 (1): 111-118.
Amelioration of Immune Cell number Depletion and Potentiation of Depressed
Detoxification System of Tumor-bearing Mice by Curcumin, Pal, Bhattacharyya, Choudhuri, et al., Cancer Detect. Prev. 2005; 29 (5):
470-478
Vitamin Antioxidants, Lipid Peroxidation, Tumour Stage, the Systemic Inflammatory Response and Survival in Patients with
Colorectal Cancer, Leung, Crozier, Talwar, et al., Int. J. Cancer 2008; 12310: 2460-2464.
Evaluation of Anti-inflammatory
Property of Curcumin (diferuloyl methane) in Patients with Postoperative Inflammation, Satoskar, Shah & Shenoy, Int.
J. Clin. Pharmacol. Ther. Toxicol. 1986; 24: 651-654.
Biological Effects of Curcumin and its Role in Cancer Chemoprevention and
Therapy, Singh & Khar, Anticancer Agents Med. Chem. 2006; 6 (3): 259-270.
Chemotherapeutic Potential of Curcumin for
Colorectal Cancer, Chauhan, Curr. Pharm. Des. 2002; 8 (19): 1695-1706
Suppression of the Nuclear Factor-kappaB Activation Pathway by Spice-derived Phytochemicals: Reasoning for Seasoning, Aggarwal & Shishodia, Ann. N. Y. Acad. Sci. 2004; 1030: 434-441.
Regression of Follicular Lymphoma with Devil’s Claw: Coincidence or Causation?, Wilson, Curr. Oncol. 2009; 16 (4): 67-70.
Curcumin Circumvents Chemoresistance in vitro and Potentiates the Effect of Thalidomide and Bortezomib Against Human Multiple Myeloma in Nude Mice Model, Sung, Kunnumakkara, Sethi, et al., Mol. Cancer Ther. 2009; 8 (4): 959-970.
Curcumin and Green Tea Polyphenols: Synergistic Anticancer Compounds, Yarnell, Quart. Rev. Nat. Med. 1998; Fall: 218-220.
Antioxidant
and Anti-inflammatory Properties of Curcumin, Menon & Sudheer, Adv. Exp. Med. Biol. 2007; 595: 105-125.
Curcumin and Resveratrol
Inhibit Nuclear Factor-kappaB-mediated Cytokine Expression in Adipocytes, Gonzales & Orlando, Nutr. Metab. (Lond). 2008; 5 (1):
17.
Regulation of COX and LOX by Curcumin, Rao, Adv. Exp. Med. Biol. 2007; 595: 213-226.
Induction of Apoptosis by
Curcumin and its Implications for Cancer Therapy, Karunagaran, Rashmi & Kumar, Curr. Cancer Drug Targets 2005; 5 (2): 117-129.
Biological
Effects of Curcumin and its Role in Cancer Chemoprevention and Therapy, Singh & Khar, Anticancer Agents Med.Chem. 2006; 6 (3):
259-270.
Chemotherapeutic Potential of Curcumin for Colorectal Cancer, Chauhan, Curr. Pharm. Des. 2002; 8 (19): 1695-1706.
Synergistic
Inhibitory Effects of Curcumin and 5-FluoroUracil on the Growth of the Human Colon Cancer Cell Line HT-29, Du, Jiang, Xia &
Zhong, Chemotherapy 2006;52 (1): 23-28.
Curcumin Inhibits Human Colon Cancer cell Growth by Suppressing Gene Expression of Epidermal
Growth Factor Receptor Through Reducing the Activity of the Transcription Factor Egr-1, Chen, Xu & Johnson, Oncogene 2005; Sept.
19, Epub.
Molecular Targets of Curcumin, Lin, Adv. Exp. Med. Biol. 2007; 595: 227-243.
Curcumin, an anti-oxidant and anti-tumor
promoter, induces apoptosis in human leukemia cells, Kuo, Huang & Lin, Biochem Biophys Acta 1996; 131 (7): 95-100.
The
Chemopreventive Agent Curcumin is a Potent Radiosensitizer of Human Cervical Tumor Cells via Increased Reactive Oxygen Species Production
and Overactivation of the Mitogen-activated Protein Kinase Pathway, Javvadi, Segan, Tuttle & Koumenis, Mol Pharmacol. 2008
May; 73 (5): 1491-501.
Curcumin, a Dietary Component, has Anti-cancer, Chemo-sensitization, and Radio-sensitization Effects
by Down-regulating the MDM2 Oncogene Through the P13K/mTOR/ETS2 Pathway, Zhang, Hill, Wang & Zhang, Cancer Res. 2007; 67 (5):
1988-1996.
Cellular Foundation of Curcumin-induced Apoptosis in Follicular Lymphoma Cell Lines, Skommer, Wlodkowic & Pelkonen,Exp. Hematol. 2006; 34 (4): 463-474.
Curcumin Inhibits Human Colon Cancer Cell Growth by Suppressing Gene Expression of Epidermal Growth
Factor Receptor Through Reducing the Activity of the Transcription Factor Egr-1, Chen, Xu & Johnson, Oncogene 2006; 25:
278-287.
Therapeutic Potential of Curcumin in Human Prostate Cancer-1. Curcumin Induces Apoptosis in Both Androgen-dependent
and Androgen-independent Prostate Cancer Cells, Dorai, Gehani & Katz, Prost. Cancer Prost. Dis. 2000; 3: 84-93.
Dietary
Curcumin Inhibits Chemotherapy-induced Apoptosis in Models of Human Breast Cancer, Somasundaram, Edmund,
Can a Common Spice be Used to Treat Cancer?, Witter, Oncolog. 2007; 52 (9): 4-5.
Curcumin
as Chemosensitizer, Limtrakul, Adv. Exp. Med. Biol. 2007; 595: 269-300.
Modulation of Function of Three Drug Transporters, P-Glycoprotein
(ABCB1), Mitoxantrone Resistance Protein (ABCG2) and Multi-drug Resistance Protein 1 (ABCC1) by Tetrahydrocurcumin, a Major Metabolite
of Curcumin, Limtrakul, Chearwae, Shukia, et al., Mol. Cell Biochem. 2007; 296 (1-2): 85-95.
Aspirin, COX-2 Inhibitors
Effective as Adjuvant Therapy in Stage III
Helicobacter Infection, Chronic Inflammation and the Development
of Malignancy, Crowe, Curr. Opin. Gastroenterol. 2005; 21 (1): 32-38.
Nutritional and Botanical Modulation of the Inflammatory
Cascade – Eicosanoids, Cyclooxygenases and Lipoxygenases – As an Adjunct in Cancer Therapy, Wallace, Integr. Cancer Ther. 2002;
1 (1): 7-37.
Inflammation, COX-2 Inhibitors, & Cancer, Block, Integr. Cancer Ther. 2005; 4 (1): 3-4.
Inflammation and
Cancer: An Ancient Link with Novel Potentials, Perwez Hussain & Harris, Int. J. Cancer 2007; 121 (11): 2373-2380.
NF-kappaB:
A Stress-regulated Switch for Cell Survival, Piva, Belardo & Santoro, Antioxid. Redox Signal. 2006; 8 (3-4): 478-486.